益華控股(02213.HK)擬獲完美中國董事長古潤金認購逾60%股份 14日復牌
格隆匯5月13日丨益華控股(02213.HK)公佈,於2020年5月12日,公司與古潤金先生訂立無法律約束力的諒解備忘錄,內容有關可能認購公司相關數目的新普通股,預期將不少於公司於緊隨可能認購事項完成後全部已發行股本的60%。
古先生,61歲,知名馬來西亞華裔企業家。古先生為完美(中國)有限公司的董事長,該公司於中國內地主要從事研究、開發、製造以及透過直接銷售銷售個人護理產品、化粧品、健康食品及家居清潔用品。古先生於完美中國的職責為監督公司的營運及管理。於本公告日期,古先生為綠科科技國際(00195.HK)的執行董事、董事會主席兼主要股東。
此外,公司股票將於2020年5月14日復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.